Dr Hannah King
Research Fellow, HIV Immunology
Department of Infectious Diseases
26 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation
DOI: 10.1128/jvi.01983-252026
Research grants (other domestic)
Silent Sparks: Decoding and Disrupting Low-Level Viremia in HIV for Real-World Cure Strategies
2026
Journal article
Immunotherapy and impact on tissue reservoirs
DOI: 10.1097/COH.00000000000009962025
Journal article
Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
DOI: 10.1016/j.jviromet.2025.1152362025
Journal article
Host-directed approaches in the pursuit of a cure for HIV
DOI: 10.1016/j.antiviral.2025.1062162025
Research grants (international)
Immune Checkpoint Blockade for Durable Control of HIV – Correlates of Efficacy
2025
Journal article
Antibody prophylaxis may mask subclinical SIV infections in macaques
DOI: 10.1038/s41586-024-08500-y
RECENT SCHOLARLY WORKS
2025
Journal article
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variants
DOI: 10.1073/pnas.24047671222025
Journal article
Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class
DOI: 10.1016/j.celrep.2024.1151632025
Journal article
HIV-1 bNAb Vaccinal Effect – An Underachieving Goal?
DOI: 10.2174/011570162X3626652507270126102024
Journal article
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
DOI: 10.1038/s41467-023-44265-02024
Journal article
Immune checkpoint inhibitors in infectious disease
DOI: 10.1111/imr.13388